| Literature DB >> 24936153 |
Amy Tankersley1, Mark Barton Frank2, Melissa Bebak2, Robert Brennan1.
Abstract
BACKGROUND: Chronic wounds such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers contribute to a considerable amount of mortality in the U.S. annually. The inability of these wounds to heal has now been associated with the presence of microbial biofilms. The aim of this study was to determine if products secreted by S. aureus biofilms play an active role in chronic wounds by promoting inflammation, which is a hallmark of chronic wounds.Entities:
Keywords: Biofilms; Gene expression microarray; Inflammation; Keratinocytes; Nitric oxide; Staphylococcus aureus
Year: 2014 PMID: 24936153 PMCID: PMC4059087 DOI: 10.1186/1476-9255-11-17
Source DB: PubMed Journal: J Inflamm (Lond) ISSN: 1476-9255 Impact factor: 4.981
Figure 1HEKa cell viability. HEKa cells were treated with Media, PCM or BCM for up to 8 hours. At 0, 2, 4, and 8 hours post exposure XTT was added and the absorbance read at 540nm. Results represent the mean and standard deviation of three independent experiments. Percent viabilities are stated as percent viable of untreated controls at each time point. (*) indicates a statistically significant difference between the treatment and the control (p < 0.05).
Change in gene expression profiles for genes that were uniquely expressed in BCM exposed HEKa cells after 2 hr of exposure
| CXCL2 (inflammation) | 15.082 | - |
| IL8 (inflammation) | 9.530 | - |
| DUSP1 (inflammation/NO prod.) | 9.061 | - |
| IL6 (inflammation/NO prod.) | 4.623 | - |
| NFKBIA (inflammation) | 4.093 | - |
| EFNA1 (inflammation) | 3.990 | - |
| TNFAIP3 (inflammation) | 3.964 | - |
| ADM (inflammation/NO prod.) | 2.917 | - |
| CXCL1 (inflammation) | 2.850 | - |
| IL1B (inflammation/NO prod.) | 2.586 | - |
| ZFP36 (inflammation) | 2.540 | - |
| IFI27 (inflammation) | 2.411 | - |
| TNF (inflammation/NO prod.) | 2.333 | - |
| IL1A (inflammation/NO prod.) | 2.113 | - |
| PTGS2 (inflammation/NO prod.) | 2.084 | - |
| SMAD7 (inflammation) | 2.073 | - |
| IL20 (inflammation) | 1.655 | - |
| IL24 (inflammation) | 1.540 | - |
| MMP1 (inflammation) | -1.650 | - |
| FOS (apoptosis) | 8.433 | - |
| ZC3H12A (apoptosis) | 4.361 | - |
| NR4A2 (apoptosis) | 4.121 | - |
| SGK1 (apoptosis) | 3.045 | - |
| CYP1B1 (apoptosis) | 2.709 | - |
| CYR61 (apoptosis) | 2.587 | - |
| BMP2 (apoptosis) | 2.481 | - |
| SLC25A24 (apoptosis) | 2.467 | - |
| CEBPD (apoptosis) | 2.419 | - |
| IFI27 (apoptosis) | 2.411 | - |
| BIRC3 (apoptosis) | 1.643 | - |
| HES1 (growth & proliferation) | 4.280 | - |
| DUSP10_v3 (growth & proliferation) | 4.091 | - |
| EFNA1 (growth & proliferation) | 3.990 | - |
| PPP1R15A (growth & proliferation) | 3.582 | - |
| JUN (growth & proliferation/NO prod.) | 3.523 | - |
| PPP1R10 (growth & proliferation) | 3.099 | - |
| HBEGF (growth & proliferation) | 3.053 | - |
| CYR61 (growth & proliferation) | 2.587 | - |
| CEBPD (growth & proliferation) | 2.419 | - |
| JUNB (growth & proliferation) | 2.405 | - |
| SMAD7 (growth & proliferation) | 2.073 | - |
| DUSP10_v1 (growth & proliferation) | 1.764 | - |
| CYR61 (wound healing) | 2.587 | - |
Genes identified through Illumina microarray results filtered to represent a 1.5 or greater fold change over the expression in the control sample.
Change in gene expression profiles for genes associated with Inflammation
| ATF3 | 8.342 | 1.663 |
| FOXA2 | 3.139 | 2.715 |
| BCL6 | 2.801 | 1.515 |
| SERPINB13 | 2.513 | 2.768 |
| RHOB | 2.443 | 1.464 |
| MMP28 | 2.117 | 1.672 |
| IL1F9 | 1.662 | 2.438 |
| PBK | -2.057 | -1.882 |
| TK1 | -2.168 | -2.029 |
| CXCL2 | 15.082 | - |
| IL8 | 9.530 | - |
| DUSP1 | 9.061 | - |
| IL6 | 4.623 | - |
| NFKBIA | 4.093 | - |
| EFNA1 | 3.990 | - |
| TNFAIP3 | 3.964 | - |
| ADM | 2.917 | - |
| CXCL1 | 2.850 | - |
| IL1B | 2.586 | - |
| ZFP36 | 2.540 | - |
| IFI27 | 2.411 | - |
| TNF | 2.333 | - |
| IL1A | 2.113 | - |
| PTGS2 | 2.084 | - |
| SMAD7 | 2.073 | - |
| IL20 | 1.655 | - |
| IL24 | 1.540 | - |
| MMP1 | -1.650 | - |
| IL28RA | - | 1.589 |
| CXCR7 | - | 2.435 |
Genes identified through Illumina microarray results filtered to represent a 1.5 or greater fold change over the expression in the control sample.
Figure 2Venn diagrams representing the number of genes that were altered in HEKa cells exposed to BCM (on the right), PCM (on the left), or shared genes (in the middle). The Venn diagram (A) represents genes associated with inflammation, (B) represents genes associated with NO production, and (C) represents genes associated with apoptosis.
Gene expression profiles for genes associated with NO production
| ARG1 | -3.042 | -2.499 |
| DUSP1 | 9.061 | - |
| IL6 | 4.623 | - |
| JUN | 3.523 | - |
| ADM | 2.917 | - |
| IL1B | 2.586 | - |
| TNF | 2.333 | - |
| IL1A | 2.113 | - |
| PTGS2 | 2.084 | - |
Genes identified through Illumina microarray results filtered to represent a 1.5 or greater fold change over the expression in the control sample.
Figure 3ELISA results for PCM, BCM and control treated HEKa cells. HEKa cells were treated with Media, PCM or BCM for up to 8 hours. The levels of cytokine production were measured after 4 and 8 hours of exposure. (A) Cytokine measurements after 4 hours of exposure. (B) Cytokine measurement after 8 hours of exposure. Measurements are reported in pg/ml concentrations. Analysis of variance (ANOVA) and Tukey’s Honestly Significant Difference were performed to identify statistically significant differences. Results represent the mean and standard deviation of three independent experiments. (#) indicates a significant difference between PCM and BCM and (*) indicates a statistically significant difference between BCM and media (p < 0.05).
Figure 4Nitrite assay. HEKa cell culture supernatants were collected and treated with Griess Reagent and absorbance was measured at 570nm. Measurements were taken at 4 and 8 hours. Measurements are reported in μM. ANOVA and Tukey’s Honestly Significant Difference were performed to identify statistically significant differences. Results represent the mean and standard deviation of three independent experiments. (#) indicates a statistically significant difference between the PCM and BCM and (*) indicates a statistically significant difference between media and BCM (p < 0.05).